This review summarizes the current literature on the risks and benefits of GLP-1 receptor agonist use for both the mother and fetus, highlighting the need for ongoing high-quality research in this population
All efficacy, safety and pharmacokinetics/pharmacodynamics endpoints are summarized descriptively by treatment group
In these situa-tions, care should not be delayed. Anesthesiologists Have the Final Say Following the AGA clinical update, Ali Rezaie, MD, director of the GI motility program at Cedars Sinai in Los Angeles, recalled there being tension among all those involved in managing preoperative care for GLP-1 users
While these do not predict exact medication response, they may help your provider contextualize your metabolic profile and decide whether liraglutide, semaglutide, tirzepatide, or another approach aligns with your genetics and health goals